Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report

Depot medroxyprogesterone acetate (DMPA) is a commonly used form of contraception, with noncontraceptive benefits for the user. The mode of action is through the suppression of ovulation. It leads to hypoestrogenism which causes dryness of the vagina and dyspareunia. We present in this paper a patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Christie, Badawy, Shawky Z. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606748/
https://www.ncbi.nlm.nih.gov/pubmed/23533869
http://dx.doi.org/10.1155/2013/835316
_version_ 1782264046892875776
author Walker, Christie
Badawy, Shawky Z. A.
author_facet Walker, Christie
Badawy, Shawky Z. A.
author_sort Walker, Christie
collection PubMed
description Depot medroxyprogesterone acetate (DMPA) is a commonly used form of contraception, with noncontraceptive benefits for the user. The mode of action is through the suppression of ovulation. It leads to hypoestrogenism which causes dryness of the vagina and dyspareunia. We present in this paper a patient that was very symptomatic with regard to vaginal atrophic changes determined by vaginal cytology. This side effect may become increasingly more common as we see more long-term use of DMPA.
format Online
Article
Text
id pubmed-3606748
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36067482013-03-26 Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report Walker, Christie Badawy, Shawky Z. A. Case Rep Obstet Gynecol Case Report Depot medroxyprogesterone acetate (DMPA) is a commonly used form of contraception, with noncontraceptive benefits for the user. The mode of action is through the suppression of ovulation. It leads to hypoestrogenism which causes dryness of the vagina and dyspareunia. We present in this paper a patient that was very symptomatic with regard to vaginal atrophic changes determined by vaginal cytology. This side effect may become increasingly more common as we see more long-term use of DMPA. Hindawi Publishing Corporation 2013 2013-03-06 /pmc/articles/PMC3606748/ /pubmed/23533869 http://dx.doi.org/10.1155/2013/835316 Text en Copyright © 2013 C. Walker and S. Z. A. Badawy. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Walker, Christie
Badawy, Shawky Z. A.
Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
title Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
title_full Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
title_fullStr Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
title_full_unstemmed Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
title_short Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
title_sort vaginal atrophy following long-term depot medroxyprogesterone acetate use: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606748/
https://www.ncbi.nlm.nih.gov/pubmed/23533869
http://dx.doi.org/10.1155/2013/835316
work_keys_str_mv AT walkerchristie vaginalatrophyfollowinglongtermdepotmedroxyprogesteroneacetateuseacasereport
AT badawyshawkyza vaginalatrophyfollowinglongtermdepotmedroxyprogesteroneacetateuseacasereport

Ejemplares similares